GO:0032044 DSIF complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032044 (DSIF complex) is a heterodimeric transcription elongation factor composed of SPT4 and SPT5 that binds RNA polymerase II and regulates promoter-proximal pausing.
• DSIF acts as a dual-function factor: it promotes RNA polymerase II pausing but can also stimulate elongation under certain conditions.
• Structural studies have resolved DSIF within paused (Pol II-DSIF-NELF) and activated (Pol II-DSIF-PAF-SPT6) elongation complexes, revealing its position near the RNA exit channel.
• DSIF functionally and physically interacts with mRNA capping enzymes, linking transcription elongation to RNA processing.
• DSIF cooperates nonredundantly with the Paf1 complex and Tat-SF1 during RNA polymerase II elongation.
• DSIF is a target of the PP2A-Integrator-CDK9 axis, which fine-tunes transcription and can be targeted therapeutically in cancer.
Description
The DSIF complex (GO:0032044) is a conserved heterodimeric transcription elongation factor formed by SPT4 and SPT5 proteins, expressed in eukaryotes from yeast to humans. It was originally identified as a factor that confers sensitivity to the transcription inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), and it is now recognized as a central regulator of RNA polymerase II (Pol II) promoter-proximal pausing. DSIF binds directly to Pol II and modulates the transition between pausing and productive elongation, making it a key node in the control of gene expression. Mechanistically, DSIF is an inhibitory elongation factor that promotes Pol II transcriptional pausing, but it can also stimulate elongation under certain conditions and may play a role in RNA processing via its physical association with mRNA capping enzymes. Structural studies have captured DSIF within paused Pol II-DSIF-NELF complexes and activated Pol II-DSIF-PAF-SPT6 complexes, providing a framework for understanding how DSIF coordinates with other elongation factors. DSIF also cooperates with the Paf1 complex and Tat-SF1 in a nonredundant manner during Pol II elongation. For researchers, the DSIF complex is important because it sits at the interface of transcription elongation, RNA processing, and cellular signaling. Its activity is fine-tuned by the PP2A-Integrator-CDK9 axis, which has therapeutic implications in cancer. Moreover, DSIF has been resolved in a transcribing Pol II-DSIF-SPT6-U1 snRNP complex, suggesting a broader role in coupling transcription with splicing-related machinery. This article summarizes the composition, mechanism, regulation, disease relevance, and experimental approaches for studying GO:0032044.
DSIF complex At A Glance
| GO ID | GO:0032044 |
|---|---|
| GO term | DSIF complex |
| Ontology | cellular_component |
| Synonym | 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole sensitivity inducing factor complex; DRB sensitivity inducing factor complex; Spt4-Spt5 complex; Spt5-Spt4 complex |
| Major function | Inhibitory elongation factor that promotes RNA polymerase II transcriptional pausing; can also stimulate elongation under certain conditions; may play a role in RNA processing via association with mRNA capping enzymes |
| Composition | Heterodimer of Spt4 and Spt5 proteins |
| Conservation | Expressed in eukaryotes from yeast to man |
| Key interacting complexes | Pol II, NELF, PAF, SPT6, Integrator, PP2A, CDK9 |
What Is GO:0032044?
The DSIF complex (GO:0032044) is a heterodimeric protein complex formed of Spt4 and Spt5 proteins which is expressed in eukaryotes from yeast to man. DSIF is an inhibitory elongation factor that promotes RNA polymerase II transcriptional pausing, but can also stimulate transcriptional elongation under certain conditions, and may play a role in RNA processing via its physical association with mRNA capping enzymes.
Why Is DSIF complex Important in Cell Biology?
The DSIF complex is a central regulator of RNA polymerase II transcription elongation and promoter-proximal pausing, processes that control the expression of most protein-coding genes. Its ability to both pause and stimulate Pol II makes it a critical integration point for signals that fine-tune transcription. DSIF also links transcription to RNA processing through its association with mRNA capping enzymes and its presence in complexes containing splicing-related factors such as U1 snRNP. Dysregulation of DSIF-associated pathways has been implicated in cancer through the PP2A-Integrator-CDK9 axis, and structural insights into DSIF-containing complexes continue to inform therapeutic strategies.
• DSIF is a conserved heterodimeric elongation factor essential for proper RNA polymerase II pausing and elongation.
• It serves as a dual-function regulator that can both inhibit and stimulate transcription elongation.
• DSIF physically associates with mRNA capping enzymes, linking transcription to RNA processing.
• Structural studies place DSIF in paused (Pol II-DSIF-NELF) and activated (Pol II-DSIF-PAF-SPT6) complexes.
• DSIF cooperates nonredundantly with the Paf1 complex and Tat-SF1 during Pol II elongation.
• DSIF is part of a transcribing Pol II-DSIF-SPT6-U1 snRNP complex, suggesting roles in splicing-related processes.
• The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer, with DSIF as a key component.
• Integrator-dependent RNA polymerase II termination involves DSIF-containing complexes.
• DSIF is a major target of the transcription inhibitor DRB, making it a tool for studying elongation control.
• Understanding DSIF function aids in interpreting gene regulatory networks and developing transcription-targeted therapeutics.
Core Biology of the DSIF Complex (GO:0032044)
Promoter-Proximal Pausing and Elongation Control
In simple terms: DSIF helps RNA polymerase II pause near the start of genes, acting like a brake that can be released when the gene needs to be fully transcribed.
DSIF is an inhibitory elongation factor that promotes RNA polymerase II transcriptional pausing, but can also stimulate transcriptional elongation under certain conditions. It binds to Pol II and is a key component of paused transcription complexes, as shown by the structure of the Pol II-DSIF-NELF complex. This pausing is a regulatory checkpoint that controls the transition to productive elongation. DSIF also cooperates with the Paf1 complex and Tat-SF1 in a nonredundant, cooperative manner during Pol II elongation. Structural studies of activated transcription complexes containing Pol II-DSIF-PAF-SPT6 have provided mechanistic insights into how DSIF participates in the switch from pausing to elongation.
Coupling Transcription with RNA Processing
In simple terms: DSIF not only controls how fast genes are read but also connects this process to the chemical modification and processing of the newly made RNA.
DSIF may play a role in RNA processing via its physical association with mRNA capping enzymes. This links transcription elongation directly to the addition of the 5' cap, a critical step for mRNA stability and translation. Furthermore, DSIF has been resolved in a transcribing Pol II-DSIF-SPT6-U1 snRNP complex, suggesting that it may coordinate transcription with splicing-related machinery. These associations position DSIF as a hub that couples the synthesis of RNA with its processing.
Structure and Composition of the DSIF Complex
In simple terms: DSIF is made of two proteins, SPT4 and SPT5, which stick together to form the functional complex.
The DSIF complex is a heterodimeric protein complex formed of Spt4 and Spt5 proteins which is expressed in eukaryotes from yeast to man. SPT4 is a small protein containing a zinc ribbon domain, while SPT5 is larger and contains multiple domains, including an N-terminal acidic region, a KOW domain, and a C-terminal repeat region (CTR). The heterodimer binds to RNA polymerase II and is found in several structural states, including paused Pol II-DSIF-NELF and activated Pol II-DSIF-PAF-SPT6 complexes. The complex is also present in a transcribing Pol II-DSIF-SPT6-U1 snRNP assembly.
Molecular Mechanism and Regulation of DSIF
In simple terms: DSIF's activity is controlled by chemical modifications and interactions with other proteins, allowing it to switch between pausing and elongation modes.
DSIF functions as a molecular brake and accelerator for Pol II, with its activity modulated by phosphorylation and interactions with other factors. The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer, and DSIF is a key component in this regulatory network. Integrator-dependent RNA polymerase II termination involves DSIF-containing complexes, indicating a role in transcription termination. Additionally, DSIF cooperates with the Paf1 complex and Tat-SF1, which are themselves regulated by cellular signaling pathways. These regulatory inputs allow DSIF to integrate diverse signals into transcriptional output.
Key Genes Involved in GO:0032044 DSIF complex
The DSIF complex is composed of two core subunits, SPT4 and SPT5, which are encoded by the genes SUPT4H1 and SUPT5H in humans, respectively; additional genes encode factors that interact with or regulate DSIF.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SUPT4H1 | Encodes SPT4, a core subunit of the DSIF complex | Essential for DSIF heterodimer formation and Pol II pausing |
| SUPT5H | Encodes SPT5, the large subunit of DSIF | Contains domains for Pol II binding, RNA capping enzyme interaction, and regulation |
| POLR2A | Encodes the largest subunit of RNA polymerase II | DSIF binds directly to Pol II to regulate pausing and elongation |
| NELF | Negative elongation factor complex | Forms paused Pol II-DSIF-NELF complexes with DSIF |
| PAF1 | Component of the Paf1 complex | Cooperates with DSIF in elongation and forms activated Pol II-DSIF-PAF-SPT6 complexes |
| SPT6 | Transcription elongation factor | Part of activated and transcribing complexes containing DSIF |
| CDK9 | Cyclin-dependent kinase 9 | Phosphorylates DSIF and other factors; part of PP2A-Integrator-CDK9 axis |
| PPP2CA | Catalytic subunit of PP2A | Dephosphorylates DSIF and other factors in the PP2A-Integrator-CDK9 axis |
| INTS11 | Integrator complex subunit | Involved in Integrator-dependent Pol II termination with DSIF |
| U1 snRNP | Splicing machinery component | Found in transcribing Pol II-DSIF-SPT6-U1 snRNP complex |
| TATSF1 | Tat-SF1 elongation factor | Cooperates nonredundantly with DSIF and Paf1 complex |
| RNGTT | mRNA capping enzyme | Physically associates with DSIF to couple transcription and capping |
| CTD | C-terminal domain of Pol II | Phosphorylation state regulates DSIF function |
| DRB | Transcription inhibitor | Used to study DSIF function via sensitivity |
| SUPT4H1 (yeast Spt4) | Yeast ortholog of SPT4 | Model for DSIF studies in Saccharomyces cerevisiae |
| SUPT5H (yeast Spt5) | Yeast ortholog of SPT5 | Model for DSIF studies in Saccharomyces cerevisiae |
How Is DSIF complex Regulated?
DSIF activity is regulated by phosphorylation and dephosphorylation events, particularly through the PP2A-Integrator-CDK9 axis, which fine-tunes transcription and can be targeted therapeutically in cancer. CDK9 phosphorylates DSIF and other elongation factors, while PP2A opposes these phosphorylation events. Integrator-dependent RNA polymerase II termination also involves DSIF-containing complexes, indicating a role in termination regulation. Additionally, DSIF cooperates with the Paf1 complex and Tat-SF1, which are themselves subject to cellular signaling regulation.
DSIF complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SUPT5H | Transcriptional dysregulation in cancer | Knockout or point mutation in cancer cell lines |
| SUPT4H1 | Neurological disorders linked to transcription pausing | Knock-in of patient variants in iPSC-derived neurons |
| CDK9 | Cancer dependency | Overexpression or knockout in leukemia models |
| PPP2CA | Cancer and transcriptional regulation | Point mutation of phosphorylation sites |
| INTS11 | Integrator-related developmental disorders | Knockout in zebrafish or mouse models |
Cancer and the PP2A-Integrator-CDK9 Axis
The PP2A-Integrator-CDK9 axis, which includes DSIF as a key component, fine-tunes transcription and can be targeted therapeutically in cancer. Dysregulation of this axis may lead to aberrant transcription elongation, contributing to oncogenesis. Targeting CDK9 or PP2A in cancers with specific dependencies has shown promise, and DSIF is a critical downstream effector.
Transcription-Associated Diseases and Therapeutic Opportunities
Given its central role in RNA polymerase II pausing and elongation, DSIF is implicated in diseases characterized by transcriptional dysregulation. Structural insights into DSIF-containing complexes, such as the Pol II-DSIF-NELF and Pol II-DSIF-PAF-SPT6 structures, provide a basis for designing inhibitors that modulate DSIF function. Integrator-dependent termination complexes containing DSIF also represent potential targets for therapeutic intervention.
RNA Processing Defects and Disease
DSIF's association with mRNA capping enzymes and U1 snRNP suggests that its dysfunction could impact RNA processing, potentially contributing to diseases linked to splicing or capping defects. However, direct disease associations remain an active area of research, and further studies are needed to establish causal links.
From DSIF complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of DSIF in promoter-proximal pausing? | Knockout of SUPT4H1 or SUPT5H in HEK293T cells followed by Pol II ChIP-seq |
| How does DSIF phosphorylation affect elongation? | Point mutation of phosphorylation sites in SUPT5H (e.g., CDK9 targets) in cancer cell lines |
| What is the effect of DSIF on RNA capping? | Knock-in of tagged SPT5 to immunoprecipitate capping enzymes in HeLa cells |
| Can DSIF be targeted therapeutically in cancer? | Overexpression of DSIF subunits in patient-derived xenografts and treatment with CDK9 inhibitors |
| How does DSIF cooperate with Paf1 complex? | Double knockout of SUPT5H and PAF1 in yeast or human cells followed by RNA-seq |
| What is the structural basis of DSIF in termination? | Knock-in of affinity tags for cryo-EM of Integrator-DSIF complexes |
How to Study the DSIF complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Steady-state mRNA levels | Global effects of DSIF knockout on gene expression |
| PRO-seq / GRO-seq | Nascent transcription and Pol II pausing | Mapping DSIF-dependent pausing sites |
| ChIP-seq | Genome-wide binding of Pol II and DSIF | Localization of DSIF at promoters and gene bodies |
| Cryo-EM | High-resolution structures of DSIF complexes | Understanding DSIF architecture in paused and activated states |
| Co-immunoprecipitation | Protein-protein interactions | Validating DSIF interactions with capping enzymes and splicing factors |
| In vitro transcription | Elongation and pausing efficiency | Mechanistic studies of DSIF function |
| DRB sensitivity assay | Sensitivity to transcription inhibitor | Classic assay for DSIF activity |
| Mass spectrometry | Identification of DSIF-associated proteins | Proteomic profiling of DSIF complexes |
Transcriptomic and Epigenomic Profiling
RNA-seq and ChIP-seq for RNA polymerase II and DSIF subunits can reveal how DSIF regulates pausing and elongation genome-wide. Knockout or knockdown of SUPT4H1/SUPT5H followed by RNA-seq identifies genes dependent on DSIF for expression. PRO-seq or GRO-seq can measure nascent transcription and pausing indices at high resolution.
Structural Biology Approaches
Cryo-electron microscopy has been used to solve structures of Pol II-DSIF-NELF, Pol II-DSIF-PAF-SPT6, and Pol II-DSIF-SPT6-U1 snRNP complexes, providing mechanistic insights. These methods require purification of endogenous or recombinant complexes, often using affinity tags on DSIF subunits.
Proteomics and Interaction Studies
Affinity purification coupled with mass spectrometry can identify DSIF-interacting proteins, including mRNA capping enzymes and splicing factors. Proximity labeling or co-immunoprecipitation can validate interactions in cells.
Functional Assays for Transcription
In vitro transcription assays using purified Pol II, DSIF, and other factors can measure the effect of DSIF on pausing and elongation. DRB sensitivity assays are classic for assessing DSIF function. Cell-based reporter assays can test the impact of DSIF mutations on transcription.
How CRISPR Can Be Used to Study GO:0032044 DSIF complex
Knockout
CRISPR knockout of SUPT4H1 or SUPT5H can abolish DSIF function, leading to defects in Pol II pausing and elongation. Such models are useful for identifying genes and pathways that depend on DSIF. Knockout cell lines can be subjected to RNA-seq and ChIP-seq to map global changes in transcription.
Point Mutation
Point mutations in SUPT5H can be introduced to study phosphorylation sites or domains required for interaction with Pol II or capping enzymes. For example, mutation of CDK9 phosphorylation sites can reveal their role in DSIF regulation. These models help dissect the molecular mechanism of DSIF in pausing and elongation.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous SUPT4H1 or SUPT5H allows for imaging and biochemical purification of DSIF complexes. Tagged knock-in models are valuable for cryo-EM studies and for tracking DSIF dynamics in live cells.
Overexpression
Overexpression of DSIF subunits can be used to study gain-of-function effects on transcription and to test whether excess DSIF promotes or inhibits elongation. Overexpression models are also useful for identifying synthetic lethal interactions with other transcription factors.
How EDITGENE Supports DSIF complex Research
Researchers studying DSIF complex-related genes often need to determine whether a candidate gene is causally involved in transcription regulation, RNA processing, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for DSIF complex research.
Frequently Asked Questions About DSIF complex
What is the DSIF complex?
The DSIF complex (GO:0032044) is a heterodimeric protein complex formed of Spt4 and Spt5 proteins that acts as an inhibitory elongation factor for RNA polymerase II, promoting transcriptional pausing but also capable of stimulating elongation under certain conditions.
What genes are involved in the DSIF complex?
The core genes are SUPT4H1 (encoding SPT4) and SUPT5H (encoding SPT5). Other interacting genes include POLR2A, NELF, PAF1, SPT6, CDK9, and PPP2CA.
What is the function of DSIF in transcription?
DSIF regulates RNA polymerase II promoter-proximal pausing and elongation, and it couples transcription with RNA processing by associating with mRNA capping enzymes.
How is DSIF regulated?
DSIF is regulated by phosphorylation and dephosphorylation, particularly through the PP2A-Integrator-CDK9 axis, which fine-tunes transcription and can be targeted in cancer.
What diseases are associated with DSIF?
DSIF is implicated in cancer through the PP2A-Integrator-CDK9 axis, and its dysfunction may affect RNA processing, though direct disease links are still being investigated.
What is the structure of the DSIF complex?
DSIF is a heterodimer of SPT4 and SPT5. It has been resolved in paused Pol II-DSIF-NELF and activated Pol II-DSIF-PAF-SPT6 complexes by cryo-EM.
How can I study DSIF using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression of SUPT4H1 and SUPT5H can be used to dissect DSIF function in transcription and disease models.
What methods are used to study DSIF?
Common methods include RNA-seq, PRO-seq, ChIP-seq, cryo-EM, co-immunoprecipitation, and in vitro transcription assays.
What is the role of DSIF in RNA processing?
DSIF physically associates with mRNA capping enzymes and is found in complexes with U1 snRNP, suggesting a role in coupling transcription with capping and splicing.
Why is DSIF a therapeutic target?
The PP2A-Integrator-CDK9 axis, which includes DSIF, can be targeted therapeutically in cancer, making DSIF a potential node for drug development.
Conclusion
The DSIF complex (GO:0032044) is a conserved heterodimeric elongation factor that controls RNA polymerase II pausing and elongation, couples transcription to RNA processing, and is regulated by the PP2A-Integrator-CDK9 axis. Its structural and functional characterization has provided deep insights into transcription regulation and opened avenues for therapeutic intervention in cancer and other diseases. Continued research using CRISPR models and advanced genomics will further elucidate its roles and potential as a drug target.
References
- 1. Zhang L et al.. 2025. Structure of a transcribing Pol II-DSIF-SPT6-U1 snRNP complex.. Nat Commun 16(1):5823 PMID: 40595577
- 2. Vos SM et al.. 2018. Structure of activated transcription complex Pol II-DSIF-PAF-SPT6.. Nature 560(7720):607-612 PMID: 30135578
- 3. Schier AC et al.. 2020. Structure and mechanism of the RNA polymerase II transcription machinery.. Genes Dev 34(7-8):465-488 PMID: 32238450
- 4. Vos SM et al.. 2018. Structure of paused transcription complex Pol II-DSIF-NELF.. Nature 560(7720):601-606 PMID: 30135580
- 5. Vervoort SJ et al.. 2021. The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer.. Cell 184(12):3143-3162.e32 PMID: 34004147
- 6. Fianu I et al.. 2024. Structural basis of Integrator-dependent RNA polymerase II termination.. Nature 629(8010):219-227 PMID: 38570683
- 7. Decker TM. 2021. Mechanisms of Transcription Elongation Factor DSIF (Spt4-Spt5).. J Mol Biol 433(14):166657 PMID: 32987031
- 8. Chen Y et al.. 2009. DSIF, the Paf1 complex, and Tat-SF1 have nonredundant, cooperative roles in RNA polymerase II elongation.. Genes Dev 23(23):2765-77 PMID: 19952111
